Treatment results of esophageal carcinoma of clinical T3, T4M0: Historical comparison between neoadjuvant chemoradiotherapy followed by surgery or definitive radiotherapy and conventional surgery

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 571-578

  Murakami, Masao ^a,b,c   Kuroda, Yasumasa ^a   Matsusue, Satoru ^a   Okamoto, Yoshiaki ^a   Nakajima, Toshifumi ^a   Nishimura, Satoru ^a   Kusumi, Fusako ^a   Hajiro, Kiyoshi ^a   Takeda, Hiroshi ^a,d  

^a TENRI HOSPITAL   (Japan)

^b Hyogo Prefectural Government   (Japan)

^c Hyogo Prefectual Government   (Japan)

^d MATSUE RED CROSS HOSPITAL   (Japan)

Author keywords

Combined modality therapy; Concurrent chemoradiotherapy; Esophageal carcinoma; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TIME;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0034181472     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.571     Document Type: Review

References (32)

1. Ilson DH and Kelsen DP: Management of esophaseal cancer. Oncology 10: 1385-1402, 1996.
2. Daly JM and Karnell LH: National Cancer Data Base report on esophageal carcinoma. Cancer 78: 1820-1828, 1996.
3. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophaseal adenocarcinoma. N Engl J Med 335: 462-467, 1996.
4. Bosset JF, Gignoux M, Triboulet JP, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337: 161-167, 1997.
5. Leichman L, Herskovic A, Leichman CG, et al: Non-operative therapy for squamous cell cancer of the esophagus. J Clin Oncol 5: 365-370, 1987.
6. Coia LR, Engstrom PF, Paul AR, et al: Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 20: 29-36, 1991.
7. Poplin EA, Jacobson J, Herskovic A, et al: Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060. Cancer 78: 1851-1856, 1996.
8. Coia LR, Soffen EM, Schultheiss TM, et al: Swallowing function in patients with esophageal carcinoma treated with concurrent radiation and chemotherapy. Cancer 71: 281-286, 1993.
9. Ohtsu A, Yoshida S, Boku N, et al: Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. Jpn J Clin Oncol 25: 261-266, 1995.
10. Kagami Y, Nishio M, Narimatsu N, et al: Treatment of squamous cell carcinoma of the esophagus with alternating radiotherapy and chemotherapy (cisplatin, methotrexate, and peplomycin). Am J Clin Oncol 20: 16-18, 1997.
11. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
12. Al-Sarraf M, Martz K, Herskovic A, et al: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15: 277-284, 1997.
13. Murakami M, Kuroda Y, Okamoto Y, et al: Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 40: 1049-1059, 1998.
14. International Union Against Cancer: Digestive system tumors. In: TNM Classification of Malignant Tumors. Hermanek P and Sobin LH (eds). 4th edition, 2nd revision. Springer-Verlag Co., Berlin, pp39-44, 1987.
15. Murakami M, Kuroda Y, Nakajima T, et al: Comparison between chemoradiation protocol intended to organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 45: 277-284, 1999.
16. Japanese Society for Esophageal Diseases: Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 8th edition. Kanehara Co., Tokyo, 1992.
17. Murakami M, Kuroda Y, Nakajima T, et al: Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma. Dis Esophagus (In press).
18. Perez CA and Brady LW (eds): Overview quantification of treatment toxicity. In: Principles and Practice of Radiation Oncology. 2nd edition. Lippincott Co., Philadelphia, pp51-55, 1992.
19. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982.
20. Japanese Research Society for Esophageal Disease: Treatment result. In: The Report of Treatment Results of Esophageal Carcinoma in Japan (1983-1987). 16th edition. National Cancer Center, Tokyo, pp17-50, 1997.
21. Giovannini M, Seitz JF, Thomas P, et al: Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer. Endoscopy 29: 4-9, 1997.
22. Hirata N, Kawamoto K, Ueyama T, et al: Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer. AJR 169: 485-491, 1997.
23. Roul A and panel of experts: Multimodality treatment for non-metastatic cancer of the thoracic esophagus: results of a consensus conference feld at the VIth World Congress of The International Society for Disease of the Esophagus. Dis Esophagus 9 (Suppl 1): 39-55, 1996.
24. Raemdonck DV, Cutsem EV, Menten J, et al: Induction therapy for clinical T4 oesophageal carcinoma: a plea for continued surgical exploration. Eur J Cardio-thoracic Surg 11: 828-837, 1997.
25. Leichman L, Steiger Z, Seydel HG, et al: Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approah. J Clin Oncol 2: 75-79, 1984.
26. Forastiere AA, Orringer MB, Perez-Tamayo C, et al: Pre-operative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11: 1118-1123, 1993.
27. Jones DR, Detterbeck FC, Egan TM, et al: Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 64: 185-192, 1997.
28. Nishimura Y, Ono K, Tsutsui K, et al: Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 30: 1099-1105, 1994.
29. Takamura A, Ohara M, Hosokawa M, et al: Combined chemotherapy with twice-daily radiation therapy for inoperable squamous cell carcinoma of the thoracic esophagus. Int J Clin Oncol 2: 189-196, 1997.
30. Hishikawa Y, Kurisu K, Taniguchi M, et al: High-dose rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 23: 107-114, 1991.
31. Gaspar LE, Qian C, Kocha WI, et al: A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Int J Radiat Oncol Biol Phys 37: 593-599, 1997.
32. Weiner LM, Colarusso P, Goldberg M, et al: Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Semin Oncol 24 (Suppl 19): S1993-S1995, 1997.